Insider Transactions in Q1 2022 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 04
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
338
-0.24%
|
-
|
|
Jan 03
2022
|
Michael S Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+15.0%
|
-
|
|
Jan 03
2022
|
Joseph L Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+3.04%
|
-
|
|
Jan 03
2022
|
George L Sing Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+0.63%
|
-
|
|
Jan 03
2022
|
Arthur F Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+0.84%
|
-
|
|
Jan 03
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$62,500
$625.07 P/Share
|
|
Jan 03
2022
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+15.0%
|
-
|
|
Jan 03
2022
|
N Anthony Coles Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+14.88%
|
-
|
|
Jan 03
2022
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+7.76%
|
-
|
|
Jan 03
2022
|
Huda Y Zoghbi Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+15.0%
|
-
|
|
Jan 03
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$625,000
$625.0 P/Share
|
|
Jan 03
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$342,000
$342.93 P/Share
|
|
Jan 03
2022
|
Christine A Poon Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+9.26%
|
-
|